Ads
related to: maintenance chemo for pancreatic cancer- Dosing & Administration
Find Important Dosing, Modification
& Administration Info for Providers
- Read The Patient Brochure
Help Patients Take An Active Role
During Treatment. Download & Share.
- Resources For Oncologists
Download Dosing Guide, Watch Videos
and More for Providers
- Prescribing Information
Provider Info for a Metastatic
Pancreatic Cancer Treatment Option
- Coverage & Access Info
Get Important Coverage Info for a
mPDAC Treatment Option
- Clinical Efficacy, Safety
See Efficacy Results & Study Info
for This Treatment Option
- Dosing & Administration
- 262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464
Search results
Results From The WOW.Com Content Network
ATO has also been shown to inhibit cancer stem cell maintenance in pancreatic cancer. [55] Several clinical trials, ranging from Phase I to Phase IV, are currently underway to test the effectiveness of ATO in both solid tumors and hematological malignancies. [12]
Pancreatic cancer: Gemcitabine, 5 ... Maintenance chemotherapy is a repeated low-dose treatment to prolong remission. ... Research suggests that in children and young ...
Vinorelbine is one of the drugs that are used for cancer treatment. Using vinorelbine as a regimen was shown to be feasible for very elderly patients who tend to have multiple comorbidities which is a condition that a patient has more than two diseases at a time, and require multiple medications [ 20 ] but, the effect of metronomic therapy is ...
A chemotherapy regimen is a regimen for chemotherapy, defining the drugs to be used, their dosage, the frequency and duration of treatments, and other considerations. In modern oncology, many regimens combine several chemotherapy drugs in combination chemotherapy. The majority of drugs used in cancer chemotherapy are cytostatic, many via ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. [4] Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation — which has spread to other parts of the body. [4]
Ad
related to: maintenance chemo for pancreatic cancer